Friday 6 November 2026
Export NEOG’s income statement to Excel — free account
Neogen Corporation
NEOG Healthcare Medical Devices
Neogen Corporation’s revenue for fiscal 2026 (year ended May 2026) was $870.4 million, down 2.72% from fiscal 2025.
- Revenue
- +6.50%
- EPS
- −129.4%
- Free cash flow
- +135.6%
- Total debt
- −2.31%
Quarter to August 2026, against a year earlier
11.88
0.20
+1.71%
Follow NEOG
Alert me
Neogen Corporation (NEOG) P/E ratio
Neogen Corporation has no meaningful P/E ratio: its trailing twelve-month earnings is negative. Over the past ten years it has ranged from 0.0× (November 2026) to 2,499× (March 2024) — the current reading is the lowest in ten years.
P/E ratio, daily
Embed this chart
Annual newest first
| Period | P/E ratio | Change |
|---|---|---|
| FY2026 | 0.0× | — |
| FY2025 | 0.0× | — |
| FY2024 | 0.0× | — |
| FY2023 | 0.0× | — |
| FY2022 | 58.8× | (25.89%) |
| FY2021 | 79.3× | 24.80% |
| FY2020 | 63.6× | 29.72% |
| FY2019 | 49.0× | (21.52%) |
| FY2018 | 62.4× | 12.52% |
| FY2017 | 55.5× | 9.01% |
Quarterly newest first
| Period | P/E ratio | Change |
|---|---|---|
| Aug 2026 | 0.0× | — |
| May 2026 | 0.0× | — |
| Feb 2026 | 0.0× | — |
| Nov 2025 | 0.0× | — |
| 43 more quarters | Free account |
Against its own ten years
Low 0.0×
High 2,499×
Ten-year median
57.3×
Current reading's percentile
25
P/E ratio against peers
| Company | P/E ratio |
|---|---|
| BFLY Butterfly Network, Inc. compare | n/m |
| ESTA Establishment Labs Holdings Inc. compare | n/m |
| NEOG Neogen Corporation | n/m |
| AXGN AxoGen, Inc. compare | n/m |
| ALMR Alamar Biosciences, Inc. compare | n/m |
| TMDX TransMedics Group, Inc. compare | 16.4× |
| INSP Inspire Medical Systems, Inc. compare | 19.1× |
| UFPT UFP Technologies, Inc. compare | 30.1× |
| ITGR Integer Holdings Corporation compare | 42.2× |
| Medical Devices industry median | 25.6× |
| Healthcare sector median | 25.2× |
| Market median | 17.9× |
What P/E ratio is
Price to Earnings Ratio shows how much investors pay for each dollar of a company’s annual profit per share.
Stock Price ÷ EPS (Basic) (TTM)
More on NEOG
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement